Venous thromboembolism (VTE) is a frequent disease affecting more than 1 in 12 individuals during their lifetime. VTE is associated with a substantial disease burden due to long-term complications such as recurrence, the post-thrombotic syndrome, and the post-pulmonary embolism syndrome. Despite the knowledge of several risk factors and triggers, more than one third of the…
Thrombosis Update Template
Write in a clean editor, then format for Thrombosis Update in one click — DocuGuru applies the official Elsevier template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
About the Thrombosis Update format
Thrombosis Update is a peer-reviewed journal published by Elsevier, covering Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes, COVID-19 Clinical Research Studies.
| Publisher | Elsevier |
|---|---|
| Reference style | Numbered (Elsevier) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, C. Lee, A representative article title, Thrombosis Update 12 (2023) 45–58.
Formats any DOI in Thrombosis Update style. No sign-up. |
| Publishes research in | Venous Thromboembolism Diagnosis and Management Atrial Fibrillation Management and Outcomes COVID-19 Clinical Research Studies Blood Coagulation and Thrombosis Mechanisms Heparin-Induced Thrombocytopenia and Thrombosis |
| ISSN | 2666-5727 |
| Citation impact (2-yr) | 1.12 |
| h-index | 15 |
| i10-index | 26 |
| Total citations | 857 |
| Article processing charge | $1,250 |
| Open access | Yes |
| Top institutions publishing here | Leiden University Medical Center |
| Journal website | www.journals.elsevier.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Papers published in Thrombosis Update per year
Citation impact of Thrombosis Update by publication year
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Most-cited papers in Thrombosis Update
Myeloproliferative neoplasms (MPNs) are clonal haematopoietic stem cell disorders characterised by myeloid progenitor proliferation in the bone marrow. Polycythaemia vera (PV), essential thrombocythaemia (ET) and primary myelofibrosis (PMF) are Philadelphia-chromosome negative classic MPNs defined as per the World Health Organization (WHO) 2016 classification and diagnostic criteria. Thrombosis, comprising of both arterial and venous events, is…
Patients with cancer are at increased risk of venous thromboembolism (VTE). Risk assessment models can help identifying high-risk populations that might benefit from primary thromboprophylaxis. Currently, the Khorana score is suggested to select patients for primary thromboprophylaxis. However, risk stratification with the Khorana-score remains imperfect, which led to the development of subsequent clinical risk assessment…
Coronavirus disease 2019 (COVID-19), caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), can cause life-threatening pathology characterized by a dysregulated immune response and coagulopathy. While respiratory failure induced by inflammation is the most common cause of death, micro-and macrovascular thrombosis leading to multiple organ failure are also causes of mortality. Dysregulation of systemic…
Introduction: Acute limb ischemia (ALI) is defined as an abrupt decrease in arterial perfusion of a limb with a threat to viability of the limb. Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2, and has been declared as a global pandemic by the World Health Organization. Patients with COVID-19 have…